세계의 개 관절염 치료 시장 규모는 2023년 27억 달러로 평가되었고, 2024년 28억 3,000만 달러에서 2032년 41억 2,000만 달러로 성장할 전망이며, 예측 기간인 2025-2032년 CAGR 4.8%로 성장할 것으로 예측됩니다.
세계 개 관절염 치료 시장은 특히 고령화, 비만, 개종이 변하기 쉬운 개에서의 변형성 관절염 유병률의 상승에 견인되어 강력한 성장을 목격하고 있습니다. 특히 선진 지역에서는 정기적인 검사 및 조기 진단 동향이 현저하고 반려동물의 주인은 이동과 통증 관리를 위해 수의학을 우선하게 되어 있습니다. 이러한 성장은 단일클론항체, 비스테로이드성 항염증제(NSAID), 재생 의학을 포함한 장기 치료제에 대한 수요 증가에 의해 더욱 촉진됩니다. 원격 의료 서비스와 온라인 동물 약국의 확대도 시장 침투를 높이고 있습니다. 동물용 의약품 기업에 의한 연구개발에 대한 일관된 투자는 시장 전망을 밝게 만듭니다. 전반적으로 반려동물용 의료 및 예방 치료에 대한 지출 증가는 개 관절염 치료 분야의 호성장을 뒷받침하고 있습니다.
Global Canine Arthritis Treatment Market size was valued at USD 2.7 billion in 2023 and is poised to grow from USD 2.83 billion in 2024 to USD 4.12 billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).
The global canine arthritis treatment market is witnessing robust growth driven by the rising prevalence of osteoarthritis, particularly in aging, obese, and breed-prone dogs. Pet owners increasingly prioritize veterinary care for mobility and pain management, with a marked trend towards regular examinations and early diagnoses, especially in developed regions. This growth is further fueled by escalating demand for long-term therapeutics, including monoclonal antibodies, NSAIDs, and regenerative medicines. The expansion of telehealth services and online veterinary pharmacies is also enhancing market penetration. Consistent investments in research and development by veterinary pharmaceutical companies underline a positive market outlook. Overall, the increase in spending on pet healthcare and preventative treatments is propelling favorable growth in the canine arthritis treatment sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Canine Arthritis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Canine Arthritis Treatment Market Segments Analysis
Global Canine Arthritis Treatment Market is segmented by Arthritis Type, Route of Administration, Treatment, End-Users, Distribution Channel and region. Based on Arthritis Type, the market is segmented into Osteoarthritis, Osteochondrosis, Rheumatoid arthritis and Traumatic arthritis. Based on Route of Administration, the market is segmented into Oral, Parenteral and Others. Based on Treatment, the market is segmented into Non-steroidal anti-inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, Allogeneic Stem Cells and Autologous Stem Cells. Based on End-Users, the market is segmented into Hospitals, Speciality Clinics and Others. Based on Distribution Channel, the market is segmented into Veterinary Hospitals & Clinics, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Canine Arthritis Treatment Market
The Global Canine Arthritis Treatment market is primarily driven by significant advancements in nutrition and veterinary medicine, which have enabled dogs to age more gracefully. As a result, there has been an increase in age-related diseases like arthritis, creating a heightened demand for wellness support and chronic care services specifically tailored for these conditions. This demographic shift highlights the growing focus on aging dogs, prompting substantial investments in treatments and medications aimed at promoting long-term joint health. Consequently, the market is evolving to meet the needs of pet owners seeking effective solutions for their canine companions suffering from arthritis.
Restraints in the Global Canine Arthritis Treatment Market
The Global Canine Arthritis Treatment market faces significant restraints due to the high costs associated with biologics and regenerative therapies, which restrict options for pet owners in low- and middle-income communities. This challenge is further exacerbated in rural areas, where there is often a shortage of veterinary specialists, making it difficult for pet owners to obtain timely diagnoses and management of these advanced therapies. These accessibility issues not only hinder the adoption of regenerative treatments but also impede the development of pet healthcare systems in emerging markets, ultimately affecting the overall growth potential of the market.
Market Trends of the Global Canine Arthritis Treatment Market
The Global Canine Arthritis Treatment market is witnessing a significant trend towards biologic and regenerative therapies, particularly monoclonal antibodies and stem cell treatments, which are leading the charge in innovative approaches. These therapies prioritize personalized care and sustainability, offering prolonged pain relief with minimal side effects, which resonates with both pet owners and veterinary professionals. This shift represents a strategic evolution in the market, emphasizing enhanced chronic care and the rapid advancement of veterinarian therapeutic solutions. As demand for more effective and less invasive treatments escalates, the market is evolving to meet these preferences, driving growth and innovation in canine arthritis management.